ICON Public Limited Company ICLR

Company Overview

ICON Public Limited Company is a global contract research organization (CRO) that provides outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. The company operates within the life sciences and healthcare services sectors, supporting clinical development from early-phase research through post-marketing studies. ICON’s core value proposition centers on helping sponsors reduce development timelines, manage regulatory complexity, and improve trial execution efficiency.

The company’s primary revenue drivers include clinical trial management, data and analytics services, laboratory services, and regulatory and safety support. ICON serves a diverse customer base ranging from emerging biotech firms to large multinational pharmaceutical companies, with a strong emphasis on complex, multinational clinical trials. Founded in 1990 in Ireland, ICON has expanded organically and through acquisitions, most notably transforming its scale and capabilities through the acquisition of PRA Health Sciences in 2021, which significantly broadened its service portfolio and global reach.